Thromboembolism in children with cancer: a retrospective multicenter study in Korea
Thromboembolism (TE) is a major cause of morbidity and mortality in adult cancer patients; however, there is a lack of sufficient knowledge on TE in pediatric cancer patients. We aimed to determine the epidemiology of TE in Korean children with cancer. Between January 2000 and July 2015, we retrospectively analyzed pediatric patients newly diagnosed with cancer at six tertiary hospitals in Korea. Of 3611 children with cancer, 33 (0.91%) had TE. A higher number of patients with acute lymphoblastic leukemia (n = 13), brain tumors (n = 6), lymphoma (n = 4), and bone/soft tissue sarcomas (n = 5) tended to develop TE. The male/female ratio was 17/16, and the median age at TE diagnosis was 10 years and 2 months. TE was detected a median of 2 months after cancer diagnosis. Symptoms including pain and swelling were present in 18 of the 33 patients. In terms of location, three intracerebral, 23 upper venous, six lower venous and one combined upper and lower venous system TEs were observed. Additional risk factors for TE included central venous catheter (CVC) use in 12 patients, steroid and/or L-asparaginase use in nine, and CVC and steroid and/or L-asparaginase use in seven. The TE incidence rate was quite low among Korean children with cancer, but higher than in the general pediatric population and among children hospitalized for diseases other than cancer. Further investigation of a larger pool of patients is warranted to determine the most effective strategies to prevent and treat TE in Korean children with cancer.
KeywordsThromboembolism Cancer Children Korea
Acute lymphoblastic leukemia
Acute myeloid leukemia
- AT III
Central nervous system
Central venous catheter
Magnetic resonance imaging
This study was supported by a grant from the Seoul National University Bundang Hospital (SNUBH) Research Fund (Grant No.: 02-2013-047).
Compliance with ethical standards
Conflict of interest
This study was approved by the Institutional Review Board of each participating institution and the Seoul National University Bundang Hospital (SNUBH) (IRB Approval No. B-1308/214-112). The need to obtain informed consent was waived by the board.
- 1.Raffini LJ, Scott JP (2016) Thrombotic disorders in children. In: Kliegman RM, Stanton BF, St Geme JW, Schor N (eds) Nelson textbook of pediatrics, 20th edn. Elsevier, Philadelphia, pp 2394–2397Google Scholar
- 2.Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D (1994) Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 83(5):1251–1257Google Scholar
- 9.Lipay NV, Zmitrovich AI, Aleinikova OV (2011) Epidemiology of venous thromboembolism in children with malignant diseases: a single-center study of the Belarusian Center for Pediatric Oncology and Hematology. Thromb Res 128(2):130–134. https://doi.org/10.1016/j.thromres.2011.03.014 CrossRefGoogle Scholar
- 28.Athale UH, Mizrahi T, Laverdière C, Nayiager T, Delva YL, Foster G, Thabane L, David M, Leclerc JM, Chan AK (2018) Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation. Pediatr Blood Cancer 65(5):e26938. https://doi.org/10.1002/pbc.26938 CrossRefGoogle Scholar
- 34.Tullius BP, Athale U, Van Ommen CH, Chan AK, Palumbo JS, Balagtas JM, Subcommittee on Hemostasis and Malignancy and the Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis (2018) The identification of at risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH. J Thromb Haemost 16(1):175–180. https://doi.org/10.1111/jth.13895 CrossRefGoogle Scholar